Inhibition of the Renin-Angiotensin System Fails to Suppress β-Aminopropionitrile-Induced Thoracic Aortopathy in Mice-Brief Report

Arterioscler Thromb Vasc Biol. 2022 Oct;42(10):1254-1261. doi: 10.1161/ATVBAHA.122.317712. Epub 2022 Aug 25.

Abstract

Background: Cross-linking of lysine residues in elastic and collagen fibers is a vital process in aortic development. Inhibition of lysyl oxidase by BAPN (β-aminopropionitrile) leads to thoracic aortopathies in mice. Although the renin-angiotensin system contributes to several types of thoracic aortopathies, it remains unclear whether inhibition of the renin-angiotensin system protects against aortopathy caused by the impairment of elastic fiber/collagen crosslinking.

Methods: BAPN (0.5% wt/vol) was started in drinking water to induce aortopathies in male C57BL/6J mice at 4 weeks of age for 4 weeks. Five approaches were used to investigate the impact of the renin-angiotensin system. Bulk RNA sequencing was performed to explore potential molecular mechanisms of BAPN-induced thoracic aortopathies.

Results: Losartan increased plasma renin concentrations significantly, compared with vehicle-infused mice, indicating effective angiotensin II type 1 receptor inhibition. However, losartan did not suppress BAPN-induced aortic rupture and dilatation. Since losartan is a surmountable inhibitor of the renin-angiotensin system, irbesartan, an insurmountable inhibitor, was also tested. Although increased plasma renin concentrations indicated effective inhibition, irbesartan did not ameliorate aortic rupture and dilatation in BAPN-administered mice. Thus, BAPN-induced thoracic aortopathies were refractory to angiotensin II type 1 receptor blockade. Next, we inhibited angiotensin II production by pharmacological or genetic depletion of AGT (angiotensinogen), the unique precursor of angiotensin II. However, neither suppressed BAPN-induced thoracic aortic rupture and dilatation. Aortic RNA sequencing revealed molecular changes during BAPN administration that were distinct from other types of aortopathies in which angiotensin II type 1 receptor inhibition protects against aneurysm formation.

Conclusions: Inhibition of either angiotensin II action or production of the renin-angiotensin system does not attenuate BAPN-induced thoracic aortopathies in mice.

Keywords: BAPN; angiotensin; angiotensinogen; aortic aneurysm; aortic dissection; renin.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aminopropionitrile / adverse effects
  • Angiotensin II
  • Angiotensinogen
  • Animals
  • Aortic Aneurysm, Thoracic* / chemically induced
  • Aortic Aneurysm, Thoracic* / genetics
  • Aortic Aneurysm, Thoracic* / prevention & control
  • Aortic Rupture* / chemically induced
  • Dilatation, Pathologic
  • Disease Models, Animal
  • Irbesartan / pharmacology
  • Losartan
  • Lysine
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Protein-Lysine 6-Oxidase / genetics
  • Receptor, Angiotensin, Type 1 / genetics
  • Renin / genetics
  • Renin-Angiotensin System*

Substances

  • Receptor, Angiotensin, Type 1
  • Angiotensinogen
  • Angiotensin II
  • Aminopropionitrile
  • Protein-Lysine 6-Oxidase
  • Renin
  • Irbesartan
  • Losartan
  • Lysine